BDX vs CAH: Which Stock Is the Better Buy?
Becton, Dickinson and Company and Cardinal Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — BDX vs CAH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Becton, Dickinson and Company (BDX) | Cardinal Health, Inc. (CAH) | |
|---|---|---|
| Market cap | $43.6B | $53.5B |
| Revenue (latest FY) | $21.84B | $222.58B |
| Net income (latest FY) | $1.68B | $1.56B |
| Revenue growth (5y CAGR) | 6.3% | 7.8% |
| Net margin | 7.7% | 0.7% |
| Return on equity | 6.6% | -56.1% |
| P/E ratio | 27.6 | 34.8 |
| Dividend yield | 2.7% | 0.9% |
| Profitable years (of last 10) | 10 | 8 |
| Positive free cash flow | Yes | Yes |
See the full BDX vs CAH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BDX's full financials → Open CAH's full financials →Frequently asked questions
Which is bigger, BDX or CAH?
Cardinal Health, Inc. is larger by market capitalization — $53.5B versus $43.6B.
Which grows faster, BDX or CAH?
Over the last five fiscal years, Cardinal Health, Inc. grew revenue faster — 7.8%/yr versus 6.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
BDX fundamentals → · CAH fundamentals → · All 1,500+ companies → · Free screener →